Transgender hormone therapy (male-to-female) medical professional. Inducers of CYP3A4 and other cytochrome P450 enzymes can reduce the effects of MTF HRT. A variety of different sex-hormonal medications are used in feminizing hormone therapy for transgender women. These include estrogens to induce feminization and suppress testosterone levels; antiandrogens such as androgen receptor antagonists, antigonadotropins, GnRH modulators, and 5α-reductase inhibitors to further oppose the effects of androgens like testosterone; and progestogens for various possible though uncertain benefits. Estrogens are the major sex hormones in women, and are responsible for the development and maintenance of feminine secondary sexual characteristics, such as breasts, wide hips, and a feminine
Fraternal birth order and male sexual orientation support a prenatal origin to sexual orientation development in men and indicate that the fraternal birth order effect is probably the result of the mother's body's “memory” for both male births as well as male gestations (i.e., every instance of being pregnant with a male fetus). So even if a male fetus was not carried to term, he still increases the likelihood of homosexuality in any subsequent male fetuses gestated by the same mother. The existence of the fraternal birth order effect on male sexual orientation has been confirmed many times. One approach for establishing the ubiquity of this effect